Pre-operative medical therapy with rosiglitazone in two patients with newly diagnosed pituitary-dependent Cushing's syndrome [3]

Clinical Endocrinology

Volumn 62, Issue 2, 2005, Pages 259-261

  Hull, Stephen S A ^a   Sheridan, Brian ^a   Atkinson, A Brew ^a  

^a ROYAL VICTORIA HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; AMINOGLUTETHIMIDE; KETOCONAZOLE; METYRAPONE; ROSIGLITAZONE;

ADULT; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CREATININE CLEARANCE; CUSHING DISEASE; DEXAMETHASONE SUPPRESSION TEST; DISEASE COURSE; DOSE CALCULATION; ENDOCRINE SURGERY; FEMALE; HUMAN; HYPOGLYCEMIA; LETTER; MICROSURGERY; NUCLEAR MAGNETIC RESONANCE IMAGING; PREOPERATIVE CARE; PRIORITY JOURNAL; SIDE EFFECT; TREATMENT OUTCOME; URINE LEVEL;

ADULT; CUSHING SYNDROME; FEMALE; HUMANS; MIDDLE AGED; PITUITARY NEOPLASMS; THIAZOLIDINEDIONES;

EID: 13444283915     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2005.02193.x     Document Type: Letter

References (12)

1. Ludecke, D.K., Flitsch, K., Knappe, U.J. & Saeger, W. (2001) Cushing's disease: a surgical view. Journal of Neuro-oncology, 54, 151-166.
2. Tsigos, C., Papanicolaou, D.A. & Chrousos, G.P. (1995) Advances in the diagnosis and treatment of Cushing's syndrome. Bailliere's Clinical Endocrinology and Metabolism, 9, 315-336.
3. Sonino, N. & Boscaro, M. (1999) Medical therapy for Cushing's disease. Endocrinology and Metabolism Clinics of North America, 28, 211-222.
4. Guilhaume, B., Bertagna, X., Thomsen, M., Bricaire, B., Vila-Porcile, E., Oliver, L., Racadot, J., Derome, P., Landat, M., Girard, F., Bricaire, H. & Luton, J. (1988) Transsphenoidal pituitary surgery for the treatment of Cushing's disease: results in 64 patients and long-term follow-up studies. Journal of Clinical Endocrinology and Metabolism, 66, 1056-1064.
5. Bochicchio, D., Losa, M., Buchfelder, M. & The European Cushing's Disease Survey Study Group (1995) Factors influencing the immediate and late outcome of Cushing's disease treated by transsphenoidal surgery, a retrospective study by the European Cushing's Disease Survey Group. Journal of Clinical Endocrinology and Metabolism, 80, 3114-3120.
6. Heaney, A.P., Fernando, M., Yong, W.H. & Melmed, S. (2002) Functional PPAR-gamma receptor is a novel therapeutic target for ACTH-secreting pituitary adenomas. Nature Medicine, 8, 1281-1287.
7. Wagstaff, A.J. & Goa, K.L. (2002) Rosiglitazone: a review of its use in the management of type 2 diabetes mellitus. Drugs, 62, 1805-1837.
8. Issemann, I. & Green, S. (1990) Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature, 347, 645-660.
9. Kubota, T., Koshizuka, K., Williamson, E.A., Asou, H., Said, J.W., Holden, S., Miyoshi, I. & Koeffler, H.P. (1998) Ligand for PPAR-gamma (troglitazone) has potent anti-tumour effects against prostate cancer both in vitro and in vivo. Cancer Research, 58, 3344-3352.
10. Sarraf, P., Mueller, P., Jones, D., King, F.J., DeAngelo, D.J., Partridge, I.E., Holden, S.A., Chen, L.B., Singer, S., Fletcher, C. & Spiegelman, B.M. (1998) Differentiation and reversal of malignant changes in colon cancer through PPAR-gamma. Nature Medicine, 4, 1046-1052.
11. Atkinson, A.B., Chestnutt, A., Crothers, E., Woods, R., Weaver, J.A., Kennedy, L. & Sheridan, B. (1984) Cyclical Cushing's disease: two distinct rhythms in a patient with a basophil adenoma. Journal of Clinical Endocrinology and Metabolism, 60, 328-332.
12. Verhelst, J.A., Trainer, P.J., Howlett, T.A., Perry, L., Rees, L.H., Grossman, A.B., Wass, J.A.H., Besser, G.M. (1991) Short and long-term response to metyrapone in the medical management of 91 patients with Cushing's syndrome. Clinical Endocrinology, 35, 169-178.